Study of Infliximab Therapy for Multiple Treatment(included IVIG)-resistant Kawasaki Disease
Not Applicable
Completed
- Conditions
- Kawasaki Disease
- Registration Number
- JPRN-jRCT1091220201
- Lead Sponsor
- Investigator-initiated Clinical Research(in-house)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients against Multiple Treatment(included IVIG)-resistant Kawasaki Disease (Under 37.5 degrees C within a 48-hour period)
Exclusion Criteria
Past History of Demyelinating Disease
Patients less than 6 months of taking BCG
Patients with lung tuberculosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ess than 37.5 degrees C within a 48-hour period after injection
- Secondary Outcome Measures
Name Time Method Complication of Coronary Artery Aneurysm after Injection<br>Complication of Coronary Artery Aneurysm after Injection(Up to One year after Injection)<br>Change of inflamatory biomarker<br>Adverse Event